2.91
6.43%
-0.20
Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
301.66%
52.40
|
13.05 | 2.159 | 30.25 | 5.678 |
Operating Expenses
|
5.30%
41.59
|
43.91 | 40.58 | 42.51 | 40.36 |
Benefits Costs and Expenses |
5.56%
38.61
|
40.89 | 37.34 | 39.09 | 37.00 |
Costs And Expenses |
5.30%
41.59
|
43.91 | 40.58 | 42.51 | 40.36 |
Provision For Loan, Lease, And Other Losses |
1.08%
0.563
|
0.557 | 0.551 | 0.545 | 0.541 |
Operating Income/Loss |
135.04%
10.82
|
-30.87 | -38.42 | -12.26 | -34.68 |
Nonoperating Income/Loss |
1.72%
2.975
|
3.027 | 3.24 | 3.422 | 3.356 |
Income/Loss From Continuing Operations Before Tax |
149.54%
13.79
|
-27.84 | -35.18 | -8.836 | -31.32 |
Income Tax Expense/Benefit |
231.05%
0.629
|
0.19 | -16.30 | 3.11 | 3.616 |
Income/Loss From Continuing Operations After Tax |
146.96%
13.16
|
-28.03 | -18.88 | -11.95 | -34.94 |
Net Income/Loss
|
146.96%
13.16
|
-28.03 | -18.88 | -11.95 | -34.94 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
273.51K%
42.23
|
0.0154 | 42.10 | 42.09 | 42.04 |
Diluted Average Shares |
285.10K%
44.02
|
0.0154 | 42.10 | 42.09 | 42.04 |
Basic Earnings Per Share |
146.27%
0.31
|
-0.67 | -0.45 | -0.28 | -0.83 |
Diluted Earnings Per Share |
144.78%
0.30
|
-0.67 | -0.45 | -0.28 | -0.83 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):